In this study, we are the first to establish a Tandem diabody and construct UCMSCs-Tandab (IL-6/CD20) and investigated the therapeutic effects of gene-modified MSCs with Tandab (IL-6/CD20) for DLBCL. The gene discussed is IL6; the disease is diffuse large B-cell lymphoma.